Findings From an Analysis of Patients With Monocytic and Monocytic-Like Acute Myeloid Leukemia (AML), Including AML-M4 and AML-M5, Treated With Venetoclax (Ven) Plus Azacitidine (Aza)

被引:0
|
作者
Konopleva, Marina [1 ]
DiNardo, Courtney [2 ]
Sun, Yan [3 ]
Loghavi, Sanam [2 ]
Jung, Paul [3 ]
Potluri, Jalaja [3 ]
Dail, Monique [4 ,5 ]
Chyla, Brenda [3 ]
Pollyea, Daniel
机构
[1] Montefiore Einstein Canc Ctr, New York, NY USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] AbbVie Inc, N Chicago, IL USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Univ Colorado, Sch Med, Aurora, CO USA
来源
关键词
acute myeloid leukemia; monocytic; venetoclax; azacitidine;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AML-095
引用
收藏
页码:S266 / S267
页数:2
相关论文
共 50 条
  • [1] Flow cytometry immunophenotypic characteristics of monocytic population in acute monocytic leukemia (AML-M5), acute myelomonocytic leukemia (AML-M4), and chronic myelomonocytic leukemia (CMML)
    Gorczyca, W
    CYTOMETRY, 4TH EDITION: NEW DEVELOPMENTS, 2004, 75 : 665 - 677
  • [2] Single center evaluation of acute monocytic leukemia (AML-M5).
    Saso, R
    Kulkarni, S
    Treleaven, J
    Paneesha, R
    Alvarez, C
    Sirohi, B
    Rudin, C
    Foukanelli, D
    Swansbury, J
    Horton, C
    Powles, R
    Catovsky, D
    BLOOD, 2000, 96 (11) : 206B - 206B
  • [3] CD14 expression and nonspecific esterase staining in acute myeloid leukemia, AML-M4 and AML-M5
    Eshoa, C
    Shidham, V
    Kouzova, M
    Kampalath, B
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 562 - 562
  • [4] Prognostic Significance of Monocytic-like Phenotype in AML Patients Treated with Venetoclax and Azacytidine
    Zhao, Lin Pierre
    Dumas-Rivero, Typhaine
    Barette, Lauren
    Aguinaga, Lorea
    Cheffai, Arij
    Lemaire, Pierre
    Mathis, Stephanie
    Chauvel, Clementine
    Dal Bello, Reinaldo
    Clappier, Emmanuelle
    Duchmann, Matthieu
    Fenaux, Pierre
    Sebert, Marie
    Ades, Lionel
    Itzykson, Raphael
    BLOOD, 2024, 144 : 4316 - 4317
  • [5] Tumor lysis syndrome (TLS) in acute myeloid leukemia (AML) patients treated with azacitidine (AZA) and venetoclax (VEN).
    Huang, Joanna Q.
    Academia, Emmeline
    Pollyea, Daniel Aaron
    Gutman, Jonathan Aaron
    Hammes, Andrew
    Chase, Stephanie
    O'Bryant, Cindy L.
    Kaiser, Jeff
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Genetic subclassification in acute monocytic leukemia (AML M5).
    Haferlach, T
    Schoch, C
    Schnittger, S
    Loeffler, H
    Kern, W
    Klaus, M
    Sauerland, MC
    Buechner, T
    Hiddemann, W
    BLOOD, 2000, 96 (11) : 104A - 104A
  • [7] Phase 2 study of azacitidine (AZA) and venetoclax (VEN) as maintenance therapy for acute myeloid leukemia (AML) patients in remission.
    Bazinet, Alexandre
    Kantarjian, Hagop M.
    Borthakur, Gautam
    Yilmaz, Musa
    Bose, Prithviraj
    Jabbour, Elias
    Valero, Yesid Alvarado
    Chien, Kelly Sharon
    Pemmaraju, Naveen
    Takahashi, Koichi
    Short, Nicholas James
    Daver, Naval Guastad
    Issa, Ghayas C.
    Jain, Nitin
    Bull-Linderman, Debra
    Dinardo, Courtney Denton
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19018 - E19018
  • [8] A case of acute monocytic leukemia (AMoL or AML-M5) in an adult FeLV/FIV-positive cat
    da Silva Serpa, Priscila Beatriz
    Messick, Joanne B.
    VETERINARY CLINICAL PATHOLOGY, 2021, 50 (01) : 158 - 163
  • [9] Cytotoxicity of Adriamycin on Monocytic Cells Derived from Acute Monocytic Leukaemia-M5 (AML-M5)-Specific-Induced Pluripotent Stem Cells
    Saik, Amy
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 1163 - 1165
  • [10] Siremadlin in Combination with Venetoclax (VEN) Plus Azacitidine (AZA) in Adult Patients with Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy: A Phase Ib/II Trial
    Daver, Naval
    Wei, Andrew H.
    Stein, Eytan
    DeAngelo, Daniel J.
    Pathak, Dhrubajyoti
    Xu, Yunnan
    Grzesiak, Stephanie
    Venditti, Adriano
    BLOOD, 2022, 140 : 11625 - 11627